SCHEMBL2903900

SCHEMBL2903900

Oc1nc(-c2ccccc2)oc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP1 O94782 1/20 0.47
▸ USP19 O94966 1/20 0.47
▸ WDR48 Q8TAF3 1/20 0.47
▸ NPC1 O15118 6/20 0.46
▸ RAB9A P51151 5/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ ATAD2 Q6PL18 1/20 0.44
▸ MAPT P10636 4/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ IKBKB O14920 1/20 0.43
▸ ELANE P08246 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ NR4A2 P43354 2/20 0.42
▸ ESR1 P03372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2364161 0.81 NR4A2 (0.45) NPC1RAB9ASMN1; SMN2CYP2C19MEN1
SCHEMBL2364162 0.81 NPC1 (0.54) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL7738122 0.78 KDM4E (0.56) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL762311 0.77 NR4A2 (0.62) USP1USP19WDR48NPC1RAB9A
SCHEMBL7796083 0.76 NOTUM (0.50) USP1USP19WDR48NPC1RAB9A
SCHEMBL11454303 0.75 SMN1; SMN2 (0.47) USP1USP19WDR48NPC1RAB9A
SCHEMBL15428324 0.75 USP1 (0.47) USP1USP19WDR48NPC1RAB9A
SCHEMBL8924884 0.75 USP1 (0.47) USP1USP19WDR48NPC1RAB9A
SCHEMBL869242 0.75 GAA (0.51) USP1USP19WDR48NPC1RAB9A
SCHEMBL5540292 0.75 USP1 (0.47) USP1USP19WDR48NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1806142-B1 Method for the production of (poly)peptides by using truncated variants of the SV 40 large T antigen with an intact N terminus RHEIN BIOTECH PROZ & PROD GMBH (DE) 2010-07-14 — — EP disclosed
EP-1806142-A1 Method for the production of (poly)peptides by using truncated variants of the SV 40 large T antigen with an intact N terminus VaDeCo Biotech GmbH & Co. KG (DE) 2007-07-11 — — EP disclosed
EP-1117803-B1 METHOD FOR THE PRODUCTION OF (POLY)PEPTIDES BY USING TRUNCATED VARIANTS OF THE SV40 LARGE T ANTIGEN WITH AN INTACT N TERMINUS VADECO BIOTECH GMBH & CO KG (DE) 2006-12-13 — — EP disclosed
EP-1117803-A1 METHOD FOR THE PRODUCTION OF (POLY)PEPTIDES BY USING TRUNCATED VARIANTS OF THE SV40 LARGE T ANTIGEN WITH AN INTACT N TERMINUS REIMANN, Hansjurg (DE) 2001-07-25 — — EP disclosed
WO-2000020606-A1 METHOD FOR THE PRODUCTION OF (POLY)PEPTIDES BY USING TRUNCATED VARIANTS OF THE SV40 LARGE T ANTIGEN WITH AN INTACT N TERMINUS REIMANN HANSJOERG (DE) 2000-04-13 — — WO disclosed
Send feedback